Protalix BioTherapeutics (PBDA.STU) Q1 2026 Earnings

18MarConfirmed
Q1 2026
-0.05
-0.02
0.01
0.03

Details

Expected EPS
0.0348944
Actual EPS
-0.0523416
Surprise EPS
-0.09
Surprise Percent
+250%

Description

Protalix BioTherapeutics (PBDA.STU) has reported earnings of -0.0523416 per share for Q1 2026.

0 Comments

Share your thoughts